BBIO earnings date and history (2026)
BridgeBio Pharma Inc. (BBIO) next reports earnings on Wed Nov 4. Analysts expect EPS of -$0.67 (8 estimates), against -$0.95 in the same quarter a year ago. Last time, on Mon Aug 10, it reported -$0.78 against a -$0.64 consensus (-21.9%). Not investment advice.
See every company reporting on the earnings calendar or the filed financial statements.
Past reports#
Newest first. The surprise is the reported EPS against the consensus going in, in percent; the move is the stock’s close-to-close change over the first session that could trade on the report, shown once that session has settled and only where the report’s session is known.
| Date | Est | Actual | Move |
|---|---|---|---|
| Aug 10, 2026 | -$0.64 | -$0.78 | — |
| May 7, 2026 | -$0.70 | -$0.84 | — |
| Feb 24, 2026 | -$0.75 | -$1.00 | — |
| Oct 29, 2025 | -$0.88 | -$0.95 | — |
About this data
Report dates, sessions, consensus EPS estimates, reported EPS and surprises come from Nasdaq's public earnings calendar and analyst pages, read daily; they are estimates, subject to change, and may not be accurate. A quarter the calendar saw is shown with its session; a quarter known only from the analyst page has none, and its move is left blank rather than guessed, because a pre-open and an after-close report trade on different sessions. The move is ChartRow's own: the first settled close that could trade on the report over the close before it, price return. Not investment advice.
FAQ#
- When does BBIO report earnings?
- BBIO is scheduled to report on Wed Nov 4, according to Nasdaq's earnings calendar. Dates are set by the company and can move.
- What EPS is expected from BBIO?
- The consensus estimate is -$0.67 a share across 8 analysts; the same quarter a year ago came in at -$0.95.
- Did BBIO beat earnings last quarter?
- No: on Mon Aug 10 BBIO reported -$0.78 against a -$0.64 consensus, a -21.9% surprise.